8 hasil untuk "...Index ..."
Menampilkan 1–8 · 0,43 detik · RSS
-
Artikel Jurnal Teks lengkap
Impatto clinico ed economico dell’emicrania in Italia: un’analisi di real-world evidence
…(ATC = N02C) between January 2010 and July 2024 were included. The index-date was defined as the first occurrence of either inclusion criterion. Patients were characterized at baseline for demographic variables and comorbidity profile. Direct healthcare costs covered by the National Health Service…
-
Artikel Jurnal Teks lengkap
Costo per responder di upadacitinib 30 mg e di dupilumab 300 mg nel trattamento di pazienti con dermatite atopica moderata-grave in Italia
…of upadacitinib ranges from a minimum of €361.50 considering EASI75 index at week 16 (Upa: €8,839.78 vs. Dup: €9,201.28) to a maximum of €50,376.18 considering EASI100 index at week 16 (Upa: €22,535.2 vs. Dup: €72,911.39). The difference in cost per responder between upadacitinib and dupilumab…
-
Artikel Jurnal Teks lengkap
Opportunità cliniche e impatto sul sistema sanitario di un trattamento ottimale del paziente post-sindrome coronarica acuta
…control of modifiable risk factors. To this aim, an optimal management of index event and appropriate preventive measures are equally important. Hospital care by cardiologists should be followed by outpatient management by general practitioners, as established by specific diagnostic and therapeutic…
Dari koleksi institusi
- INDEXGROLIER BUSINESS -p · 1999 · UNILAK
- Merck Index · Universitas Riau (UNRI)
-
Artikel Jurnal Teks lengkap
Lifestyle and incident dementia: A COSMIC individual participant data meta‐analysis
INTRODUCTION: The LIfestyle for BRAin Health (LIBRA) index yields a dementia risk score based on modifiable lifestyle factors and is validated in Western samples. We investigated whether the association between LIBRA scores and incident dementia is moderated by geographical location or…
-
Artikel Jurnal Teks lengkap
Costo per responder di risankizumab e secukinumab nel trattamento della psoriasi a placche da moderata a grave in Italia
…of published efficacy data as measured by Psoriasis Area and Severity Index response (PASI 90 and PASI 100) for risankizumab and secukinumab. The treatment cost was based on the number of administrations dispensed in the first (induction plus maintenance period) and the second (maintenance period…
-
Artikel Jurnal Teks lengkap
Costo per responder del metotrexato rispetto ad altre terapie in pazienti con psoriasi a placche da moderata a grave in Italia
…The primary analysis assessed the CPR of both Psoriasis Area and Severity Index (PASI) 90 at weeks 12 and 52. A secondary analysis was conducted considering PASI 75. For methotrexate, both an average dosage of 13.4 mg, estimated by an expert panel, and a dosage of 15 mg reported in European…
-
Artikel Jurnal Teks lengkap
Carcinoma a cellule renali metastatico: evidenze real-world da un ampio database amministrativo italiano
…and lymph node and/or distant metastases in the same hospital discharge (index date) were selected in 2015. Metastases were defined new if they were absent in the 2 previous years. Patients were described in terms of gender, age (mean ± SD) and comorbidities of interest. The 2-year survival and…
-
Artikel Jurnal Teks lengkap
Costo per NNT di upadacitinib nel trattamento dei pazienti con dermatite atopica da moderata a severa in Italia
…(EASI-75) or ≥ 90 (EASI-90) from baseline of the eczema area and severity index (EASI). Only the ex-factory price of the targeted systemic therapies was considered. The cost per NNT was adopted as a cost-effectiveness indicator. RESULTS: At 16 weeks, the cost per NNT based on EASI-75 was lower for…